Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-16

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved Ascend Laboratories' supplemental application for methylphenidate hydrochloride (generic). This approval authorizes the manufacture of a generic me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylphenidate hydrochloride (generic) (Methylphenidate hydrochloride)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)